| 1.83 Data as of May 21 |  +0.15 / +8.93%Today’s Change | 1.00 Today|||52-Week Range 7.10 | -20.78% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $46.3M |
BG Medicine, Inc. 610 North Lincoln Street Waltham Massachusetts 02451-2188 |
| Individual stakeholders | 40.89% |
| Mutual fund holders | 17.86% |
| Other institutional | 14.21% |
| Paul R. Sohmer, MD | President, Chief Executive Officer & Director |
| Anastasia Rader | Senior VP-Executive Operations & Human Resources |
| Charles H. Abdalian, Jr., MBA | CFO, Treasurer, EVP & Head-Investor Relations |
| Carol A. Adiletto | Vice President-Clinical & Regulatory Affairs |
| Aram S. Adourian, PhD | Chief Scientific Officer & Senior Vice President |
.
